Literature DB >> 7508483

Use of Merocyanine 540 and Hoechst 33258 for the selective killing of contaminating mycoplasmas in cell cultures.

M Tarshis1, A Katzenel, S Rottem.   

Abstract

Mycoplasma infection can substantially affect the biological properties of cells in vitro. We have devised a method for the selective killing of mycoplasmas, e.g., A. laidlawii, M. fermentans, M. hyorhinis and M. arginini, from experimentally infected cell cultures. This approach is based on the differential binding of the lipophilic fluorescent probe Merocyanine 540 followed by illumination with visible light. The efficiency of the procedure depends on the Merocyanine 540 concentration, the intensity of illumination, and the presence of oxygen in the medium. When A. laidlawii contaminated corneal endothelial cell cultures were treated simultaneously with Merocyanine 540 and DNA-binding fluorochrome Hoechst 33258 and then illuminated, a significant degree of eradication was observed, even after one cycle of treatment. This combined treatment is therefore recommended as an effective method of purging mycoplasmas from contaminated cultures.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7508483     DOI: 10.1016/0022-1759(94)90061-2

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  3 in total

1.  Arginine consumption as a monitor of mycoplasma infection of cultured cells.

Authors:  J Capiaumont; C Legrand; B Dousset; F Belleville; P Nabet
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995 Jul-Aug       Impact factor: 2.416

2.  Use of merocyanine 540 for photodynamic inactivation of Staphylococcus aureus planktonic and biofilm cells.

Authors:  Hsiao-Yin Lin; Chin-Tin Chen; Ching-Tsan Huang
Journal:  Appl Environ Microbiol       Date:  2004-11       Impact factor: 4.792

3.  Purification of Encephalitozoon cultures contaminated by mycoplasmas by murine intraperitoneal inoculation.

Authors:  O Ridoux; C Foucault; M Drancourt
Journal:  J Clin Microbiol       Date:  1998-08       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.